Revival of effective and safe high-dose mizoribine for the kidney transplantation

Clinical Transplantation

Volumn 20, Issue 5, 2006, Pages 590-595

  Sugitani, Atsushi ^a   Kitada, Hidehisa ^a   Ota, Morihito ^a   Yoshida, Junichi ^a   Doi, Atsushi ^a   Hirakata, Hideki ^a   Tanaka, Masao ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Acute rejection; Donor; Immunosuppression; Kidney transplantation; Mizoribine; Pancreas transplantation

Indexed keywords

ALLOPURINOL; ANTIMETABOLITE; AZATHIOPRINE; CYCLOSPORIN A; MIZORIBINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS;

ACUTE GRAFT REJECTION; ADULT; ARTICLE; BODY WEIGHT; BONE MARROW SUPPRESSION; CADAVER KIDNEY; CLINICAL ARTICLE; COST EFFECTIVENESS ANALYSIS; CREATININE BLOOD LEVEL; DIARRHEA; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; DRUG SOLUBILITY; DRUG SUBSTITUTION; FEMALE; GRAFT RECIPIENT; HUMAN; HYPERURICEMIA; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; KIDNEY DISEASE; KIDNEY FUNCTION; KIDNEY PANCREAS TRANSPLANTATION; KIDNEY TRANSPLANTATION; LIVING DONOR; LYMPHOPROLIFERATIVE DISEASE; MALE; POSTOPERATIVE CARE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL;

ADOLESCENT; ADULT; ANTIMETABOLITES; AZATHIOPRINE; FEMALE; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; MYCOPHENOLIC ACID; PANCREAS TRANSPLANTATION; RIBONUCLEOSIDES; TACROLIMUS;

EID: 33748666598     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2006.00522.x     Document Type: Article

References (17)

1. Mizuno K, Tsujino M, Takada M et al. Studies on Bredinin. Isolation, characterization and biological properties. J Antibiot 1974: 27: 775.
2. Inou T, Kusaba R, Takahashi I et al. Clinical trail of Bredinin in renal transplantation. Transpl Proc 1981: 13: 315.
3. Amemiya H, Suzuki S, Niiya S, Watanabe H, Kotake T. Synergistic effect of Cyclosporine and Mizoribine on survival of dog renal allografts. Transplantation 1988: 46: 768.
4. Hosokawa S, Ogino T, Ihara H et al. Triple-drug therapy with Mizoribine, Cyclosporine and Methylprednisolone (Japanese). Ishoku 1988: 24: 21.
5. Konishi K, Saruta T, Abe S et al. Prediction of creatinine clearance from the serum creatinine concentration. Jap J Nephrol 1984: 26: 1195.
6. Sugitani A, Motoyama K, Yamamoto H et al. How to use Mizoribine in kidney and pancreas transplantation (Japanese). Kurinika 2004: 31: 320.
7. Hager PW, Collart FR, Humberman E, Mitchell BS. Recombinant human inosine monophosphate dehydrogenase type I and type II proteins, purification and characterization of inhibitor binding. Biochem Pharmacol 1995: 49: 1323.
8. Tanabe K, Tokumoto T, Ishikawa N et al. Long-term results in Mizoribine-treated renal transplant recipients: A prospective, randomized trial of Mizoribine and Azathioprine under Cyclosporine-based immunosuppressant. Transpl Proc 1999: 31: 2877.
9. Ishikawa H. Mizoribine and Mycophenolate mofetil. Curr Med Chem 1999: 6: 575.
10. Sonda K, Takahashi K, Tanabe K et al. Clinical pharmacokinetic study of Mizoribine in renal transplantation patients. Transpl Proc 1996: 28: 3643.
11. Ihara H, Shinkuma D, Kubo M et al. Clinical significance of the blood level monitoring of Mizoribine in kidney transplant recipients (Japanese). Ishoku 1993: 29: 47.
12. European Mycophenolate Mofetil Cooperative Study Group. Placebo-controlled study of mycophenolate mofetil combined with cyclosporine and corticosteroids for prevention of acute rejection. Lancet 1995: 345: 1321.
13. The Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group. A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation. Transplantation 1998: 61: 69.
14. Tanabe K. Re-evaluation of Mizoribine for renal transplantation (Japanese). Ther Res 2002: 23: 992.
15. Tian Y, Xiao X, Tang Y, Ao J, Zhang L, Zhang Y. A prospective randomized comparative trial of Mizoribine versus mycophenolate mofetil for efficacy and safety in renal transplantation. Transpl Now 2005: 18: 107.
16. Abe Y, Tsuji Y, Hisano M et al. Pharmacokinetic study of Mizoribine in an adolescent with lupus nephritis. Pediatr Int 2004: 46: 597.
17. Akiyama T, Okazaki H, Takahashi K et al. Mizoribine in combination therapy with tacrolimus for living donor renal transplantation. Transpl Proc. 2005: 37: 843.